dc.contributor.author
Soler Prat, Concepció
dc.contributor.author
Comes Beltran, Núria
dc.contributor.author
Callejo, Gerard
dc.contributor.author
Gasull Casanova, Xavier
dc.contributor.author
Llimós Aubach, Júlia
dc.contributor.author
Andres Bilbe, Alba
dc.contributor.author
Pujol Coma, Anna
dc.contributor.author
Castellanos Aida
dc.contributor.author
Pallás, Irene
dc.contributor.author
Bahamonde, Maria Isabel
dc.contributor.author
Anta Vinyals, Josep Maria de
dc.date.issued
2026-01-23T11:33:57Z
dc.date.issued
2026-01-23T11:33:57Z
dc.date.issued
2024-12-02
dc.date.issued
2026-01-23T11:33:57Z
dc.identifier
https://hdl.handle.net/2445/226017
dc.description.abstract
A subset of peripheral sensory neurons expressing specific Mas-related G-protein-coupled receptors and transient receptor potential channels mediate pruritogen-induced chemical itch. However, the molecular mechanisms that regulate the excitability of these cells, and consequently itch sensation, are poorly understood. TWIK-related spinal cord K + channel (TRESK) is a background K + channel that modulates the resting membrane potential, action potential firing, and neuronal excitability, and it has been involved in somatosensation and pain transduction. Here, we demonstrate that this channel contributes to pruritic transduction and it is a potential target for treating chronic itch pathologies. TRESK channel coexpress with Mas-related G-protein-coupled receptor A3, MrgprC11 and MrgprD in mouse sensory neurons, and with MrgprX1 in human ones. Genetic ablation of TRESK enhances firing of MrgprA3-expressing pruriceptors and acute itch in response to intradermal injection of chloroquine, while the response to histamine, BAM8-22, or leukotriene C4 remains unaffected. TRESK deletion also exacerbates chronic itch in mouse models of allergic contact dermatitis, dry skin, and imiquimod-induced psoriasiform dermatitis, resulting in a significantly increased scratching behavior that develops earlier and is more robust. Moreover, pharmacologically enhancing TRESK function diminishes both acute and chronic itch in wild-type mice but not in TRESK knockout (KO) animals. In summary, our data indicate that TRESK plays a role in regulating the excitability of a subset of sensory neurons that mediate histaminergic-independent itch. Enhancing the channel function with specific activators represents a promising antipruritic therapeutic approach that can be combined with other compounds for the treatment of nonhistaminergic itch, which currently lack adequate treatment options.
dc.format
application/pdf
dc.publisher
Wolters Kluwer Health
dc.relation
Versió postprint del document publicat a: https://doi.org/10.1101/2024.01.25.577205
dc.relation
Pain, 2024, vol. 166, num.8, p. 1796-1810
dc.relation
https://doi.org/10.1101/2024.01.25.577205
dc.rights
(c) International Association for the Study of Pain, 2024
dc.rights
info:eu-repo/semantics/openAccess
dc.subject
Malalties de la pell
dc.subject
Receptors neurals
dc.subject
Neural receptor
dc.title
TRESK background potassium channel in MrgprA3<sup>+</sup> pruriceptors regulates acute and chronic itch
dc.title
TRESK background potassium channel in MrgprA3^+ pruriceptors regulates acute and chronic itch. (accepted)
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/acceptedVersion